Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Enanta Pharmaceuticals Inc
About ENTA
Enanta Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. The Company’s clinical programs are focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including receptor tyrosine kinase (KIT) and STAT6 inhibition. The Company has two clinical-stage product candidates for RSV, which are zelicapavir and EDP-323. Glecaprevir, a protease inhibitor discovered by the Company, is part of one of the treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in various countries under the tradenames MAVYRET (U.S.) and MAVIRET (ex-U.S.) (glecaprevir/pibrentasvir). The Company also has development programs in virology for SARS-CoV-2 and Hepatitis B virus.
Find out what a historical investment in Enanta Pharmaceuticals Inc would be worth today using our ENTA stock calculator.
Market Capitalisation
$400.12M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
161.2K
High today
$14.24
Low today
$13.54
Open price
$13.76
52-week high
$17.15
52-week low
$5.55
Ready to start your investing journey with Stake?
Open an accountHow do I buy ENTA shares in Australia?
Buying ENTA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Enanta Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ENTA
What is the ticker symbol of Enanta Pharmaceuticals Inc?
The ticker symbol for Enanta Pharmaceuticals Inc is ENTA.
How much is one share of ENTA?
One share of ENTA is valued at $13.58 as of 20 May 2026.
What is the market capitalisation of Enanta Pharmaceuticals Inc ENTA?
As of 20 May 2026 Enanta Pharmaceuticals Inc has a market cap of $400.12M.
What is the 52-week high for Enanta Pharmaceuticals Inc stock?
The Enanta Pharmaceuticals Inc 52-week high stock price is $17.15.
What is the 52-week low for Enanta Pharmaceuticals Inc stock?
The Enanta Pharmaceuticals Inc 52-week low stock price is $5.55.
Can I buy ENTA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ENTA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ENTA on Stake
- Buy ENTA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ENTA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ENTA related stocks